Literature DB >> 6421481

Pineal ablation in varying photoperiods and the incidence of 9,10-dimethyl-1,2-benzanthracene induced mammary cancer in rats.

L S Kothari, P N Shah, M C Mhatre.   

Abstract

Our earlier observation of increased incidence of 9,10-dimethyl-1,2-benzanthracene (DMBA) induced mammary carcinoma in young, virgin 'functionally' pinealectomized Holtzman rats poses the question whether or not a comparable incidence would occur in surgically pinealectomized rats reared in varying photoperiods (e.g. light/dark (LD) 24/0 or LD 10/14 schedules). Results show that functionally or surgically pinealectomized rats in LD 24/0 schedule have comparable mammary tumor incidence (95% and 83%, respectively) and latency period of tumor appearance (60 +/- 3.1 and 69.2 +/- 6.6 days, respectively). However, when surgically pinealectomized rats were kept in short photoperiods (LD 10/14), a significant difference was observed in both tumor incidence (60.9%) and latency period (91.8 +/- 11.0 days). Our data suggest that the susceptibility of the mammary gland to carcinogenic insult may be modulated by the concentration of the pineal hormone, melatonin, in the CNS.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6421481     DOI: 10.1016/0304-3835(84)90050-8

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  5 in total

1.  Inhibitory effects of the pineal hormone melatonin and underfeeding during the promotional phase of 7,12-dimethylbenzanthracene-(DMBA)-induced mammary tumorigenesis.

Authors:  D E Blask; S M Hill; K M Orstead; J S Massa
Journal:  J Neural Transm       Date:  1986       Impact factor: 3.575

Review 2.  Breast cancer and circadian disruption from electric lighting in the modern world.

Authors:  Richard G Stevens; George C Brainard; David E Blask; Steven W Lockley; Mario E Motta
Journal:  CA Cancer J Clin       Date:  2013-12-24       Impact factor: 508.702

3.  Pineal melatonin inhibition of tumor promotion in the N-nitroso-N-methylurea model of mammary carcinogenesis: potential involvement of antiestrogenic mechanisms in vivo.

Authors:  D E Blask; D B Pelletier; S M Hill; A Lemus-Wilson; D S Grosso; S T Wilson; M E Wise
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

4.  Melatonin blocks the stimulatory effects of prolactin on human breast cancer cell growth in culture.

Authors:  A Lemus-Wilson; P A Kelly; D E Blask
Journal:  Br J Cancer       Date:  1995-12       Impact factor: 7.640

Review 5.  Melatonin: An Anti-Tumor Agent in Hormone-Dependent Cancers.

Authors:  Javier Menéndez-Menéndez; Carlos Martínez-Campa
Journal:  Int J Endocrinol       Date:  2018-10-02       Impact factor: 3.257

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.